Reduction of Polypharmacy in Elderly People With Multiple Diseases

NARecruitingINTERVENTIONAL
Enrollment

1,146

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

December 31, 2025

Conditions
PolypharmacyMultimorbidity
Interventions
OTHER

Medication plan review

Intervention group patients will receive a revised medication plan by external pharmacologist based on the the STOPP/START criteria. The revised medication plan will be provided to the family physician who then will provide it to the patient. The revision comes along with evidence based information for the physician to prevent possible uncertainties by the physicians.

BEHAVIORAL

Adherence support

Intervention group patients will receive a study nurse administered adherence support measure based on telephone-based motivational interviewing. The measure includes information on possible consequences of inadherence and signs of adverse drug reactions that is comprehensible for lay persons.

Trial Locations (1)

06110

RECRUITING

HAP ANZ, Halle

All Listed Sponsors
collaborator

University of Leipzig

OTHER

collaborator

Hannover Medical School

OTHER

lead

Martin-Luther-Universität Halle-Wittenberg

OTHER